Rational Vaccines, a biotechnology company and leaders in herpes research, have finished their Phase I Clinical Trial of the Theravax vaccine for patients with herpes simplex virus 1 and 2 (HSV-1, HSV-2). Results found that this medication may be the “functional cure” for both diseases.